Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,140 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
How I treat rituximab refractory patients with WM.
Gavriatopoulou M, Ntanasis-Stathopoulos I, Kastritis E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: dimopoulos ma. Oncotarget. 2018 Dec 7;9(96):36824-36825. doi: 10.18632/oncotarget.26411. eCollection 2018 Dec 7. Oncotarget. 2018. PMID: 30627320 Free PMC article. No abstract available.
Treatment of Waldenström's macroglobulinemia with rituximab.
Dimopoulos MA, Zervas C, Zomas A, Kiamouris C, Viniou NA, Grigoraki V, Karkantaris C, Mitsouli C, Gika D, Christakis J, Anagnostopoulos N. Dimopoulos MA, et al. J Clin Oncol. 2002 May 1;20(9):2327-33. doi: 10.1200/JCO.2002.09.039. J Clin Oncol. 2002. PMID: 11981004 Clinical Trial.
How we treat Waldenström's macroglobulinemia.
Dimopoulos MA, Merlini G, Leblond V, Anagnostopoulos A, Alexanian R. Dimopoulos MA, et al. Haematologica. 2005 Jan;90(1):117-25. Haematologica. 2005. PMID: 15642678 Review.
Management of relapsed and relapsed refractory myeloma.
Kastritis E, Mitsiades CS, Dimopoulos MA, Richardson PG. Kastritis E, et al. Among authors: dimopoulos ma. Hematol Oncol Clin North Am. 2007 Dec;21(6):1175-215, x. doi: 10.1016/j.hoc.2007.08.014. Hematol Oncol Clin North Am. 2007. PMID: 17996594 Review.
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
Anargyrou K, Terpos E, Vassilakopoulos TP, Pouli A, Sachanas S, Tzenou T, Masouridis S, Christoulas D, Angelopoulou MK, Dimitriadou EM, Kalpadakis C, Tsionos K, Panayiotidis P, Dimopoulos MA, Pangalis GA, Kyrtsonis MC; Greek Myeloma Study Group. Anargyrou K, et al. Among authors: dimopoulos ma. Haematologica. 2008 Mar;93(3):451-4. doi: 10.3324/haematol.11852. Epub 2008 Feb 20. Haematologica. 2008. PMID: 18287135
Rituximab-based treatments in Waldenström's macroglobulinemia.
Dimopoulos MA, Kastritis E, Roussou M, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Tassidou A, Terpos E. Dimopoulos MA, et al. Clin Lymphoma Myeloma. 2009 Mar;9(1):59-61. doi: 10.3816/CLM.2009.n.015. Clin Lymphoma Myeloma. 2009. PMID: 19362975 Review.
Treatment of relapsed/refractory multiple myeloma.
Kastritis E, Palumbo A, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Semin Hematol. 2009 Apr;46(2):143-57. doi: 10.1053/j.seminhematol.2009.01.004. Semin Hematol. 2009. PMID: 19389498 Review.
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).
Kastritis E, Kyrtsonis MC, Hadjiharissi E, Symeonidis A, Michalis E, Repoussis P, Tsatalas C, Michael M, Sioni A, Kartasis Z, Stefanoudaki E, Voulgarelis M, Delimpasi S, Gavriatopoulou M, Koulieris E, Gika D, Zomas A, Roussou P, Anagnostopoulos N, Economopoulos T, Terpos E, Zervas K, Dimopoulos MA; Greek Myeloma Study Group. Kastritis E, et al. Among authors: dimopoulos ma. Leuk Res. 2010 Oct;34(10):1340-3. doi: 10.1016/j.leukres.2010.04.005. Epub 2010 May 5. Leuk Res. 2010. PMID: 20447689
Prognostication of the high-risk WM patient.
Kastritis E, Gavriatopoulou M, Kyrtsonis MC, Michael M, Hadjiharissi E, Symeonidis A, Michalis E, Repoussis P, Tsatalas K, Sioni A, Kartasis Z, Stefanoudaki E, Voulgarelis M, Delimpasi S, Gika D, Vervesou E, Konstantopoulos K, Kokkini G, Zomas A, Roussou P, Anagnostopoulos N, Economopoulos T, Terpos E, Zervas K, Dimopoulos MA. Kastritis E, et al. Among authors: dimopoulos ma. Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):127-9. doi: 10.3816/CLML.2011.n.028. Clin Lymphoma Myeloma Leuk. 2011. PMID: 21454212
1,140 results